ADH1B and non-small cell lung carcinoma: After constructing the organ-tissue location network of potential anti-NSCLC therapeutic targets of H. cordata (Fig. 2), we found that a total of nine potential therapeutic targets were distributed in the lung, including ADH1B, XDH, ALOX5, CA4, CFD, FABP4, ICAM1, MMP12, and SLC6A4.